Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 26 Feb 2026 for VERTEX PHARMACEUTICALS INC / MA, €717k. Read the official filing
Filing timeline
BuySaleCharles F. Wagner Jr.
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles F. Wagner Jr.: trading record in brief
This profile gathers the share dealings of Charles F. Wagner Jr. in Vertex Pharmaceuticals INC / MA, where the filings describe the role as finance chief. In total, 39 filings cover trades dated from 30 April 2021 to 24 February 2026.
No open-market purchase appears, only 13 sales worth €12.0M. The rest of the record consists of 25 share grants and 1 option exercise.
The record was last updated on 26 February 2026 with a share grant (€717k) in Vertex Pharmaceuticals INC / MA. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles F. Wagner Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
1,744 shares@ US$485.118.9% of flowCommon StockSEC:0000875320-26-000122:0
7,365 shares0Common StockSEC:0000875320-26-000100:0
4,565 shares@ US$487.7623.3% of flowCommon StockSEC:0000875320-26-000078:0
3,045 shares@ US$468.4114.9% of flowCommon StockSEC:0000875320-26-000054:0
9,440 shares0Common StockSEC:0000875320-26-000028:0
9,532 shares@ US$189.3819.1% of flowCommon StockSEC:0000875320-26-000002:0
7,000 shares@ US$451.00100.0% of flowCommon StockSEC:0000875320-25-000247:0
3,298 shares@ US$500.006.4% of flowCommon StockSEC:0000875320-25-000148:0
4,962 shares@ US$479.619.5% of flowCommon StockSEC:0000875320-25-000137:0
3,310 shares@ US$483.286.4% of flowCommon StockSEC:0000875320-25-000117:0
2,293 shares@ US$463.464.3% of flowCommon StockSEC:0000875320-25-000097:0
6,655 shares0Common StockSEC:0000875320-25-000075:0
2,649 shares@ US$467.985.1% of flowCommon StockSEC:0000875320-25-000050:0
10,262 shares0Common StockSEC:0000875320-25-000026:0
3,000 shares@ US$518.276.1% of flowCommon StockSEC:0000875320-24-000227:0
3,250 shares@ US$460.005.8% of flowCommon StockSEC:0000875320-24-000170:0
3,250 shares@ US$454.795.7% of flowCommon StockSEC:0000875320-24-000162:0
3,309 shares@ US$431.795.6% of flowCommon StockSEC:0000875320-24-000111:0
3,750 shares@ US$424.016.2% of flowCommon StockSEC:0000875320-24-000082:0
2,607 shares@ US$422.744.3% of flowCommon StockSEC:0000875320-24-000057:0
5,814 shares0Common StockSEC:0000875320-24-000034:0
3,000 shares@ US$405.004.6% of flowCommon StockSEC:0000875320-24-000002:0
3,000 shares@ US$349.884.1% of flowCommon StockSEC:0000875320-23-000043:0
1,768 shares@ US$305.382.1% of flowCommon StockSEC:0001209191-23-021394:0
360 shares@ US$294.520.4% of flowCommon StockSEC:0001209191-23-020244:0
25 of 39 declarations
